FDA Breaks New Ground With First Approved Gene Therapy for Cancer – Singularity Hub
Singularity Hub |
FDA Breaks New Ground With First Approved Gene Therapy for Cancer
Singularity Hub Co-developed with the drug giant Novartis, the therapy, CAR–T, genetically alters a patient's own immune cells to target and destroy cancer cells. Recently, in a historic decision, the FDA threw their support behind Kymriah (tisagenlecleucel), a … |
